Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 797-807 , December 2010

Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model

  • Ahmet Erten, MSEE

      Affiliations

    • Department of Nanoengineering, University of California San Diego, San Diego, California, USA
    • ,
  • Wolf Wrasidlo, PhD

      Affiliations

    • University of California San Diego Moores Cancer Center, San Diego, California, USA
    • ,
  • Miriam Scadeng, MD

      Affiliations

    • Department of Radiology, University of California San Diego, San Diego, California, USA
    • ,
  • Sadik Esener, PhD

      Affiliations

    • Department of Nanoengineering, University of California San Diego, San Diego, California, USA
    • ,
  • Robert M. Hoffman, PhD

      Affiliations

    • Department of Surgery, University of California San Diego, San Diego, California, USA
    • AntiCancer Inc., San Diego, California, USA
    • ,
  • Michael Bouvet, MD

      Affiliations

    • University of California San Diego Moores Cancer Center, San Diego, California, USA
    • Department of Surgery, University of California San Diego, San Diego, California, USA
    • ,
  • Milan Makale, PhD, MSEE

      Affiliations

    • University of California San Diego Moores Cancer Center, San Diego, California, USA
    • Corresponding Author InformationCorresponding author:

Received 8 March 2010 ,Accepted 14 June 2010.

References 

  1. McCarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev. 2008;60:1241–1251
  2. Mikhaylova M, Stasinopoulos I, Kato Y, Artemov D, Bhujwalla ZM. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. Cancer Gene Ther. 2009;16:217–226
  3. Koenig SH, Kellar KE. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med. 1995;34:227–233
  4. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem. 1999;10:186–191
  5. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med. 1992;25:148–157
  6. Le Duc G, Vander Elst L, Colet JM, Roch A, Gillis P, Le Bas JF, et al. Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: a dose-effect study. J Magn Reson Imaging. 2001;13:619–626
  7. Coroiu I. Relaxivities of different superparamagnetic particles for application in NMR tomography. J Magnetism Magn Mater. 1999;201:449–452
  8. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11:2319–2331
  9. LaConte L, Nitin N, Bao G. Magnetic nanoparticle probes. Materials Today. 2005;8:32–38
  10. Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging. 1995;13:675–691
  11. Casadei MA, Cerreto F, Cesa S, Giannuzzo M, Feeney M, Marianecci C, et al. Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations. Int J Pharm. 2006;325:140–146
  12. Lin Y, Salek MFS, Jennings N, Gmitro AF. An optical imaging system for window chambers in MRI system. SPIE. 2008;6849:684907.1–684907.5
  13. Gaustad JV, Brurberg KG, Simonsen TG, Mollatt CS, Rofstad EK. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia. 2008;10:354–362
  14. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta. 1991;1066:29–36
  15. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990;268:235–237
  16. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta. 1991;1062:77–82
  17. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta. 1990;1029:91–97
  18. Woodle MC, Newman MS, Cohen JA. Sterically stabilized liposomes: physical and biological properties. J Drug Target. 1994;2:397–403
  19. Cashion MP, Long TE. Biomimetic design and performance of polymerizable lipids. Acc Chem Res. 2009;42:1016–1025
  20. Lopez E, O'Brien DF, Whitesides TH. Effects of membrane composition and lipid structure on the photopolymerization of lipid diacetylenes in bilayer membranes. Biochim Biophys Acta. 1982;693:437–443
  21. O'Brien DF, Klingbiel RT, Specht DP, Tyminski PN. Preparation and characterization of polymerized liposomes. Ann N Y Acad Sci. 1985;446:282–295
  22. Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, Lutu-Fuga K, et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A. 2008;105:9343–9348
  23. Barbarese E, Ho SY, D'Arrigo JS, Simon RH. Internalization of microbubbles by tumor cells in vivo and in vitro. J Neuro-Oncol. 1995;26:25–34
  24. Kim IS, Jeong YI, Kim SH. Self-assembled hydrogel nanoparticles composed of dextran and poly(ethylene glycol) macromer. Int J Pharm. 2000;205:109–116
  25. Endrich B, Asaishi K, Gotz A, Messmer K. Technical report—a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl). 1980;177:125–134
  26. Menger MD, Jager S, Walter P, Hammersen F, Messmer K. A novel technique for studies on the microvasculature of transplanted islets of Langerhans in vivo. Int J Microcirc Clin Exp. 1990;9:103–117
  27. Makale M. Intravital imaging and cell invasion. Methods Enzymol. 2007;426:375–401
  28. Makale M. Chapter 8. Noninvasive imaging of blood vessels. Methods Enzymol. 2008;444:175–199
  29. Katz MH, Bouvet M, Takimoto S, Spivack D, Moossa AR, Hoffman RM, et al. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Cancer Res. 2003;63:5521–5525
  30. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M, et al. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res. 2003;113:151–160
  31. Katz MH, et al. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Res. 2004;64:1828–1833
  32. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715–724

 This research was funded by the National Institutes of Health.

PII: S1549-9634(10)00166-8

doi: 10.1016/j.nano.2010.06.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 797-807 , December 2010

Article Tools

* Image Usage & Resolution